Enochian Biosciences Inc·4

May 20, 9:32 PM ET

Sindlev Rene 4

4 · Enochian Biosciences Inc · Filed May 20, 2022

Insider Transaction Report

Form 4
Period: 2022-05-18
Sindlev Rene
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2022-05-18$8.00/sh+125,000$1,000,000125,000 total(indirect: By RS Arving ApS)
  • Purchase

    Common Stock

    2022-05-18$8.00/sh+128,493$1,027,944128,493 total(indirect: By RS Group ApS)
Holdings
  • Common Stock

    (indirect: By RS Bio ApS)
    9,668,351

Documents

1 file
  • 4
    ownership.xmlPrimary